|
EIF2C2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.059500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.402300E-02 |
| Normal-vs-Stage2 |
1.303600E-03 |
| Normal-vs-Stage3 |
3.211800E-04 |
| Normal-vs-Stage4 |
5.648400E-02 |
| Stage1-vs-Stage2 |
8.240100E-02 |
| Stage1-vs-Stage3 |
8.325900E-02 |
| Stage1-vs-Stage4 |
8.588200E-01 |
| Stage2-vs-Stage3 |
4.890600E-01 |
| Stage2-vs-Stage4 |
9.236200E-02 |
| Stage3-vs-Stage4 |
1.455420E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.318190E-02 |
| Normal-vs-AfricanAmerican |
5.520400E-01 |
| Normal-vs-Asian |
8.302800E-03 |
| Caucasian-vs-AfricanAmerican |
2.674800E-01 |
| Caucasian-vs-Asian |
4.993800E-01 |
| AfricanAmerican-vs-Asian |
1.182600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.380740E-04 |
| Normal-vs-Female |
1.419930E-02 |
| Male-vs-Female |
3.712200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.122100E-02 |
| Normal-vs-Age(41-60Yrs) |
8.354200E-04 |
| Normal-vs-Age(61-80Yrs) |
4.170400E-04 |
| Normal-vs-Age(81-100Yrs) |
1.735760E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.391700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.517900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.229600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.821000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.414800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.387400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.091400E-01 |
| Classical-VS-Follicular |
3.81770000057458E-08 |
| Classical-VS-Other |
1.003770E-01 |
| Classical-VS-Normal |
8.713600E-02 |
| Tall-VS-Follicular |
5.436300E-03 |
| Tall-VS-Other |
6.498400E-02 |
| Tall-VS-Normal |
2.796300E-02 |
| Follicular-VS-Other |
9.766200E-01 |
| Follicular-VS-Normal |
7.39929999493683E-08 |
| Other-VS-Normal |
1.782330E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.10160000000603E-05 |
| Normal-vs-N1 |
4.815500E-02 |
| N0-vs-N1 |
1.155780E-01 |
|
|
